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Many proteins first identified in the immune system are also expressed in the developing and adult nervous
system. Unexpectedly, recent studies reveal that a number of these proteins, in addition to their immunolog-
ical roles, are essential for the establishment, function, and modification of synaptic connections. These
include proinflammatory cytokines (e.g., TNFa, IL-6), proteins of the innate immune system (e.g., comple-
ment C1q and C3, pentraxins, Dscam), members of the major histocompatibility complex class I (MHCI)
family, and MHCI-binding immunoreceptors and their components (e.g., PIRB, Ly49, DAP12, CD3z). Under-
standing how these proteins function in neuronswill clarify themolecular basis of fundamental events in brain
development and plasticity and may add a new dimension to our understanding of neural-immune interac-
tions in health and disease.Introduction
The ‘‘one gene-one protein’’ model has long been discarded in
the face of evidence that numerous cellular processes, including
differential splicing and posttranslational modification, can allow
a single gene to encode multiple distinct protein products. These
modifications vastly increase the number of protein functions
that can be encoded by a limited DNA genome. More recently,
it has become apparent that even identical proteins can have
more than one role in different tissues, cell types, or subcellular
domains (Cirulli and Yebra, 2007; Radisky et al., 2009; Wegrzyn
et al., 2009). In this way, one protein can control multiple, appar-
ently unrelated phenotypic features, a feature termed pleiotropy.
Pleiotropy is an emerging concept in proteomics and may
provide an unexpected mechanism for the coordination of dispa-
rate cellular functions (Radisky et al., 2009).
A large number of proteins that were first discovered in the
immune system have since been detected in the healthy, unin-
fected nervous system, raising the possibility that these proteins
have pleiotropic functions in neurons (Boulanger et al., 2001).
Indeed, accumulating evidence indicates that several immune
proteins have novel, nonimmune functions in the brain. These
include proinflammatory cytokines (e.g., TNFa, IL-6), proteins
of the innate immune system (e.g., complement C1q and C3),
proteins of the adaptive immune system (e.g., members of the
major histocompatibility complex class I [MHCI] family), and
MHCI-binding immunoreceptors and their components (e.g.,
PIRB, Ly49, DAP12, CD3z). Similarly, a smaller number of
proteins that were first discovered in the nervous system have
since been found to have immunological functions (e.g., Dscam,
semaphorins). Rather than provide an exhaustive overview of
proteins that have both immune and neuronal functions, this
review focuses on recent evidence that specific immune proteins
are required for normal brain development and synaptic plas-
ticity. In the past I have described some of these as immune
proteins ‘‘moonlighting’’ in the brain (Boulanger et al., 2001).However, ‘‘moonlighting’’ implies that the brain is not the site
of their ‘‘day job.’’ Referring to them as immune proteins, while
necessary for clarity, may create a similar conceptual barrier.
The current research suggests that these terms may need to
be revised to reflect evidence that immune and neural roles of
these proteins are essential to different cellular and systems
functions and may in fact be equally significant.
Expression of Immune Proteins in the Nervous System
Immune responses in the brain are blunted and often have
slower kinetics (reviewed in Carson et al., 2006), giving rise to
the idea that the central nervous system is ‘‘immune privileged.’’
Although the brain’s relative isolation from the immune system
was originally thought to stem, in part, from a lack of key immune
proteins in neurons, numerous studies have since revealed that
many of these immune proteins are expressed in both neuronal
and nonneuronal cell types in the central and peripheral nervous
system. However, the expression of these proteins in the
nervous system is often spatially and temporally regulated in
a manner that is more consistent with nonimmunological roles.
One striking example is proteins of the MHCI, key players in
adaptive immunity. The MHCI is a large family of proteins that
are expressed on the surface of most nucleated cells in the
body. Cell-surface MHCI presents peptides derived from intra-
cellular proteins for immune surveillance, permitting immune
recognition of foreign (‘‘nonself’’) antigens generated by trans-
planted, infected, and cancerous tissues. MHCI mRNA
(Figure 1A) and protein (Figures 3A and 3C) are expressed in
subsets of neurons and are spatially and developmentally regu-
lated. In the mammalian brain, MHCI expression is particularly
high in regions undergoing activity-dependent plasticity,
including the developing visual system and adult hippocampus
and cerebellum (Corriveau et al., 1998; Huh et al., 2000; Letellier
et al., 2008; McConnell et al., 2009). Furthermore, different
members of the MHCI gene family are expressed in the brainNeuron 64, October 15, 2009 ª2009 Elsevier Inc. 93
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Figure 1. Expression of mRNA Encoding MHCI and
Immunoreceptors for MHCI in Healthy Adult Rodent Brain
S35 labeling using antisense probes against specific MHCI mRNAs or mRNAs
encoding particular MHCI immunoreceptors in sections of adult mouse brain
(in B–D, light areas indicate silver grains).
(A) Pseudocolored in situ hybridization showing mRNA encoding three
different MHCI genes in three overlayed serial coronal sections of adult mouse
brain. Red, H2-D; blue, T22; green, Qa-1. Reprinted with permission from Bou-
langer et al. (2001).
(B) Paired immunoglobulin-like receptor B (PIRB) mRNA detected in a sagittal
section. Scale, 1 mm. Reprinted with permission from Syken et al. (2006),
copyright 2006 National Academy of Sciences, USA.
(C) Killer cell immunoglobulin-like receptor-like gene (KIRL) mRNA detected in
a sagittal section. Olfactory bulb (OB), hippocampal dentate gyrus (DG), and
cerebellum (CB). Modified with permission from Bryceson et al. (2005).
(D) Unrecombined T cell receptor beta subunit (TCRb) mRNA detected
in a sagittal section. Reprinted with permission from Syken and Shatz
(2003).94 Neuron 64, October 15, 2009 ª2009 Elsevier Inc.in distinct, characteristic patterns (Huh et al., 2000; Lidman et al.,
1999) (Figure 1A). MHCI protein is enriched in synaptic fractions
(Huh et al., 2000), and in hippocampal neurons in vitro, MHCI
protein is detected in dendrites, where it colocalizes with the
postsynaptic marker PSD-95 (Goddard et al., 2007) (Figure 3A).
Immunoreceptors for MHCI have also been detected in the
adult mammalian brain (Figures 1B–1D), including the immuno-
globulin-like receptor B (PIRB) (Syken et al., 2006), the killer
cell immunoglobulin-like receptor-like (KIRL) receptor (Bryceson
et al., 2005), and unrecombined T cell receptor beta subunit
(TCRb) (Syken and Shatz, 2003). Recombination-activating
gene 1 (RAG1), which is required for somatic recombination of
TCR genes in lymphocytes, is widely expressed in embryonic
and postnatal neurons and is coexpressed with RAG2 in olfac-
tory sensory neurons (OSNs) (Chun et al., 1991; Jessen et al.,
2001). It is as yet unknown if more of the dozens of known
MHCI immunoreceptors are expressed in the brain, but it is
notable that MHCI is much more widely expressed than any of
the immunoreceptors examined to date (Figure 1 shows expres-
sion of just three of the more than 50 MHCI mRNAs expressed in
mouse).
Proteins of the innate immune system are also expressed in
neurons in patterns consistent with nonimmunological roles.
C1q and C3, components of the classical complement cascade,
are expressed in a punctuate pattern in the developing (but not
adult) brain, and a subset of C1q protein colocalizes with
synaptic markers in the early postnatal retina. Like MHCI,
expression of C1q in the developing visual system peaks during
the period of activity-dependent remodeling (Stevens et al.,
2007). Interleukin- (IL-) 6 and IL-6 receptor mRNAs are also
coexpressed in neurons and are developmentally regulated in
rat brain, with highest levels of both detected in adult hippo-
campus (Gadient and Otten, 1994).
Neurons themselves express immune proteins, but they can
also be affected by secreted and cell-surface immune proteins
produced by infiltrating immune cells (e.g., lymphocytes), micro-
glia (the resident CNS macrophage), and other resident neuroglia
(e.g., astrocytes, oligodendrocytes). Indeed, although neurons
can produce tumor necrosis factor- (TNF)- a, glia are the source
of the endogenous TNFa that affects synaptic scaling (see
below): wild-type (WT), TNFa-expressing neurons plated on
WT glia show robust synaptic scaling in response to activity
blockade with tetrodotoxin (TTX), while WT neurons plated on
glia purified from TNFa knockout mice do not (Stellwagen and
Malenka, 2006). Similarly, although the immunoreceptor compo-
nent DAP-12 is detected in microglia, but not neurons, genetic
ablation of DAP-12 modifies neuronal glutamate receptor
expression and synaptic plasticity (Roumier et al., 2004).
Neurons can also be induced to express immune proteins as
the result of interactions with glia. For example, retinal ganglion
cells (RGCs) upregulate proteins of the complement cascade
in response to astrocytes (Stevens et al., 2007).
Immune Proteins in Normal Brain Development
The expression of immune proteins in the early postnatal brain
suggests that these proteins may be involved in developmental
processes in the central nervous system. Numerous immune
proteins are expressed in neuronal stem cells, suggesting that
Neuron
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and Palmer, 2009 [this issue of Neuron]). In addition, immune
proteins have been implicated in later neurodevelopmental
events, including multiple steps in the establishment and matu-
ration of synaptic connections.
Neurite Guidance and Synapse Formation
The high molecular diversity of some immune protein families
makes them attractive candidates for mediating specific intercel-
lular recognition events during the establishment of precise
neuronal connectivity. One such familyof proteins is theDrosophila
Dscams, and their vertebrate homologs, the DSCAMs (Down
Syndrome Cell Adhesion Molecules). In Drosophila, alternative
splicing of the immunoglobulin (Ig) domains of Dscam can permit
the generation of up to 38,016 Dscam isoforms (Schmucker
et al., 2000) (Figure 2A). Although Dscam was first identified in
neurons, in invertebrates, Dscams are thought to function in the
Figure 2. Dscam Encodes Diverse Proteins
that Display Homophilic Binding and
Mediate Normal Self-Avoidance between
Sister Neurites or between Neurites of
a Single Cell Type
(A) Constant and variable regions in the Dscam
gene in Drosophila. Differential splicing of exons
4, 6, 9, and 17 can produce up to 38,016 distinct
Dscam mRNA isoforms. Modified with permission
from Wojtowicz et al. (2004).
(B) Schematic illustration of the molecular basis of
Dscam homophilic interactions. In most cases,
matching at all three variable domains is required
for binding. Modified with permission from Sawaya
et al. (2008).
(C) Homophilic binding between Dscam isoforms
that vary only at the IgG3 domain. Ig3 domains
are arranged according to their sequence related-
ness, as shown in the dendrograms, and binding
is indicated as fold over background by a color
scale and the number in each block. Red diagonal
line indicates that binding is preferentially homo-
philic. Reprinted with permission from Wojtowicz
et al. (2007).
(D) Loss of Dscam in single Drosophila neurons
causes extensive dendritic self-crossing of sister
branches of the same cell, resulting in tangled
and disorganized dendritic fields in dendritic
arborization (da) class I neurons. This phenotype
is rescued by expression of either of two specific
Dscam isoforms (1.30.30.1 or 11.31.25.1) in single
neurons in an otherwise Dscam null background.
Scale, 10 mm. Modified with permission from
Hughes et al. (2007).
(E) Whole adult (6–8 week) wild-type (WT, left) or
Dscam/ (right) mouse retinas stained with anti-
TH. Dopaminergic amacrine cell neurites arborize
evenly, while in mice lacking DSCAM, amacrine
cell neurites are bundled in thick fascicles. Modi-
fied with permission from Fuerst et al. (2008).
innate immune response, possibly through
their ability to bind directly to bacteria;
soluble Dscam is secreted into the hemo-
lymph in flies, and loss of Dscam specifi-
cally in hemocytes impairs phagocytosis
of bacteria (Watson et al., 2005).
In addition to its expression in immune
cells, Dscam and DSCAM are also
expressed in the invertebrate and vertebrate nervous system,
respectively. In flies, a single neuron can express more than
one Dscam isoform (Neves et al., 2004; Zhan et al., 2004), and
although the mechanisms that drive alternative splicing remain
unclear, it appears that the process is largely stochastic but
can be biased by cell type (Neves et al., 2004). The Dscams
examined to date participate in homophilic interactions between
their highly diverse extracellular domains (Wojtowicz et al., 2004,
2007) (Figures 2A–2C). Remarkably, both the presence and
absence of homophilic Dscam interactions may be used to
specify neuronal wiring. In Drosophila, homophilic binding
between Dscams triggers repulsion between sister dendrites,
leading to dendritic self-avoidance (Hughes et al., 2007;
Matthews et al., 2007; Soba et al., 2007) (Figure 2D), and triggers
repulsion between sister axons, leading to axon tiling (Millard
et al., 2007). Although heterophilic binding between DscamNeuron 64, October 15, 2009 ª2009 Elsevier Inc. 95
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absence of homophilic binding maybe an important cue for devel-
oping circuits. This is perhaps analogous to ‘‘missing self’’ recog-
nition in the immune system, in which cells that have downregu-
lated cell-surface MHCI in an attempt to evade immune
surveillance fail to bind to MHCI receptors on the surface of NK
cells, triggering NK cell-mediated lysis. Support for a neuronal
role for a lack of homophilic Dscam interactions comes from
a series of elegant experiments in which the diversity of the
Dscams was genetically reduced, either by generating alleles
that reduce the maximum possible diversity to 22,176 isoforms
(Chen et al., 2006), by using homologous recombination to reduce
the repertoire of extracellular domains to a single isoform (Hattori
et al., 2007), or by reintroducing single Dscam isoforms into indi-
vidual Dscam null mutant neurons on an otherwise wild-type
background (Chen et al., 2006). In all three cases, the likelihood
of ectopic homophilic interactions was increased, and in all three
cases connectivity defects were observed, consistent with the
possibility that Dscam-mediated ‘‘missing self’’ recognition is
important for proper neuronal wiring in Drosophila. These tech-
niques all share the caveat that the eliminated isoforms may
have included one or a pool of isoforms that are essential for
connectivity and that this, rather than the overall reduction of
Dscam molecular diversity, gave rise to the defects. Indeed,
Chen et al. (2006) argue that changes in the projections of neurons
expressing a single Dscam isoform support the possibility that
neurons use particular isoforms for specific aspects of neuronal
branching patterns. However, while much evidence indicates
that homophilic Dscam-mediated self-recognition interactions
are important for self-avoidance, instructive functional differences
between individual isoforms have not yet been demonstrated.
Dscams and/or DSCAMs have also been implicated in
commissural axon guidance (Ly et al., 2008), laminar specificity
of axonal arborization in the retina (Yamagata and Sanes,
2008), and targeting of olfactory neuron axons to the correct
glomeruli (Hummel et al., 2003; Zhan et al., 2004) (reviewed in
Schmucker and Chen, 2009). Despite the fact that the enormous
isoform diversity of Dscam appears to be unique to arthropods,
recent genetic analyses of DSCAM in the vertebrate brain reveal
an intriguing conservation of molecular function in specifying
neural wiring. In the mouse, as in the fly, DSCAM is required
for prevention of neurite fasciculation (Figure 2E) as well as for
normal mosaic spacing of cell bodies (Fuerst et al., 2008), forms
of self-avoidance within a single cell type. It is as yet unclear how
DSCAM affects vertebrate wiring in the absence of massive iso-
form diversity, but in some systems it may function as a repulsive
cue (Fuerst et al., 2008) or as a kind of molecular ‘‘non-stick
coating’’ (R. Burgess, personal communication), in either case
preventing synapses from forming between DSCAM-expressing
cells. Conversely, separate studies on the role of DSCAM in
retinal lamination in the mouse (Yamagata and Sanes, 2008)
suggest that DSCAMs can act as attractive or adhesive cues.
These differences in the way DSCAMs behave in a given cell
type or species suggest that DSCAMs, like many guidance mole-
cules, can function as either attractants or repellents, depending
on the cellular context (Yamagata and Sanes, 2008).
A smaller family of immune-related proteins, the neuronal pen-
traxins, have been implicated in the regulation of synapse96 Neuron 64, October 15, 2009 ª2009 Elsevier Inc.number, most likely by controlling synapse formation. In the
humoral immune response, pentraxins are secreted proteins
that mark cells for phagocytosis and degradation. Two neuronal
pentraxins have been identified to date: neuronal pentraxin 1, or
NP1, which was identified based on its ability to bind to the snake
venom toxin taipoxin (Schlimgen et al., 1995), and neuronal
activity-regulated pentraxin, or Narp (also known as NP2), which
was identified as an immediate-early gene that is induced by
physiological levels of electrical activity (Tsui et al., 1996). While
they are not identical to other pentraxins, the C-terminal domains
of the neuronal pentraxins NP1 and Narp are homologous to the
classic innate immune system pentraxins. Neuronal pentraxins
are detected at excitatory synapses and regulate excitatory
synapse number. Narp overexpression increases the number
of excitatory synapses (O’Brien et al., 1999; Xu et al., 2003), while
dominant-negative Narp decreases the number of excitatory
synapses (O’Brien et al., 2002). Both neuronal pentraxins are
secreted and form large, covalently linked heteromultimers
with themselves and the recently identified transmembrane
neuronal pentraxin receptor (NPR), and formation of this
complex synergistically enhances their synapse-promoting
function (Xu et al., 2003). The NPR may also serve a dominant-
negative function when it is cleaved following mGluR1/5 activa-
tion, releasing the pentraxin domain. This causes the pentraxin
domain to accumulate in endosomes along with AMPARs. This
simultaneous relocalization of AMPARs and the NPR pentraxin
domain from the cell surface to an intracellular compartment is
required for the induction of mGluR1/5-dependent LTD (Cho
et al., 2008), suggesting that neuronal pentraxin signaling may
be involved in the weakening as well as the formation of
synapses.
It is likely that neuronal pentraxins regulate synapse number
by promoting excitatory synapse formation, since neuronal pen-
traxins are sufficient to induce clustering of AMPA receptors in
both neuronal and nonneuronal cells (O’Brien et al., 1999; Xu
et al., 2003), and dominant-negative Narp decreases the ability
of axons to induce GluR1 clusters on contacted dendrites
(O’Brien et al., 2002). However, pentraxins are also required for
normal developmental synapse remodeling (see below), a pro-
cess that requires both the formation of appropriate synapses
and the removal of inappropriate synapses. In light of the finding
that the neuronal pentraxin receptor is involved in the functional
weakening of synapses (Cho et al., 2008), it will be of interest to
determine if neuronal pentraxins regulate synapse number
through changes in synapse elimination as well as synapse
formation.
Developmental Synapse Refinement
Proteins of both the innate and adaptive immune system have
been identified that are essential for activity-dependent synapse
refinement in the developing brain (Table 1), a key step in estab-
lishing the precision of adult circuits. MHCI was first implicated
in mammalian brain development when it was identified in an
unbiased screen for genes involved in the activity-dependent
remodeling of retinal ganglion cell (RGC) axons projecting to
the developing lateral geniculate nucleus (LGN) (Corriveau
et al., 1998). These retinogeniculate projections are initially
exuberant, with inputs from the two eyes overlapping in the
LGN at birth. During the first two postnatal weeks, these retinal
Neuron
ReviewTable 1. Activity-Dependent Plasticity in the Developing and Adult Visual System of Mice with Altered Expression of Specific Immune
Proteins
Activity-Dependent Synapse Elimination
Developmental Retinogeniculate Remodeling
Manipulation Phenotype Reference
MHCI-deficient (b2 m–/–TAP–/–) enlarged ipsilateral projection (P30) Huh et al., 2000
CD3z–/– enlarged ipsilateral projection (P30) Huh et al., 2000
C1q–/– increased ipsilateral/contralateral overlap (P30) Stevens et al., 2007
C3–/– increased ipsilateral/contralateral overlap (P30) Stevens et al., 2007
C1q–/– more low-amplitude functional inputs (P30) Stevens et al., 2007
PIRB-TM ipsilateral projection normal (P30) Syken et al., 2006
Visual Cortical Plasticity during Critical Period (Deprivation-Induced)
TNFa–/– no increase in strength of response to open eye (P26–P30);
decrease in deprived eye normal
Kaneko et al., 2008
PIRB-TM enhanced expansion of cortical representation of open eye (P19–P25) Syken et al., 2006
NgR–/– normal expansion of cortical representation of open eye (P24) McGee et al., 2005
Visual Cortical Plasticity after Critical Period (Deprivation-Induced)
TNFa–/– normal critical period for MD-induced plasticity (P33) Kaneko et al., 2008
PIRB-TM extended critical period for MD-induced plasticity (P22–P31,
P31–P36, P100–P110)
Syken et al., 2006
NgR–/– extended critical period for MD-induced plasticity (P45, P120) McGee et al., 2005
Nogo A–/– extended critical period for MD-induced plasticity (P45, P120) McGee et al., 2005
Retinogeniculate remodeling is impaired in MHCI-deficient animals, CD3z-deficient animals, and complement C1q- or C3-deficient animals, but not
PIRB-deficient animals. Deprivation-induced visual cortical plasticity is enhanced during the critical period in PIRB-deficient animals, but not NgR-KO
animals; the critical period is extended in mice lacking either PIRB, NgR, or NogoA, but not in mice lacking TNFa.inputs undergo activity-dependent remodeling to segregate into
eye-specific regions, establishing the mature pattern of connec-
tivity necessary for binocular vision. MHCI mRNA is highly
expressed in the developing cat and mouse LGN during retino-
geniculate remodeling (Corriveau et al., 1998; Huh et al., 2000),
and furthermore, developmental refinement of retinal axons is
impaired in MHCI-deficient (b2 m/TAP/) mice, such that
inappropriate projections that would normally be eliminated
instead persist (Huh et al., 2000). Thus, in the developing brain,
MHCI is required for the normal developmental elimination of
inappropriate projections, perhaps analogous to its role in the
immune system, where it permits recognition and removal of
unwanted cells expressing ‘‘nonself’’ antigens. Although MHCI
genes are expressed in the adult cerebellum (Figure 3C), subse-
quent studies have found that MHCI is not required for normal
activity-dependent remodeling of climbing fiber-Purkinje cell
projections (Letellier et al., 2008; McConnell et al., 2009). This
may reflect mechanistic differences in remodeling in these brain
regions or may indicate that the MHCI genes found in these two
brain regions are functionally specialized in terms of their role in
remodeling.
Proteins of the classical complement cascade (encoded in
the MHC class III region) are also required for retinogeniculate
remodeling and seem to act in the final stages of this process
(Stevens et al., 2007). In the immune response, complement
proteins bind to bacteria and other foreign material that has
been marked for phagocytosis and clearance. C1q, the initiating
protein in the classical complement cascade, is produced by
astrocytes as well as by astrocyte-stimulated neurons. C1q isexpressed widely in the postnatal brain, and C1q-deficient (as
well as C3-deficient) mice show an impairment in retinogenicu-
late synapse elimination. Interestingly, the impairment is of a
similar magnitude (Stevens et al., 2007) to that seen in MHCI-
deficient mice (Huh et al., 2000). In C1q-deficient animals,
each LGN neuron receives a higher number of functional inputs
than in WT, as measured electrophysiologically, confirming the
anatomical failure of synapse elimination. Most LGN neurons
receive one strong input and multiple weak inputs in C1q-defi-
cient animals, versus the single strong input seen in WT animals
at this age (Stevens et al., 2007). This suggests that loss of C1q
prevents structural, but not functional, weakening of retinal
inputs during development. Thus, C1q may be involved in elim-
inating synapses that have already lost the competition; if so, it
is permissive but not instructive for synapse elimination, similar
to its role in the immune system.
Neuronal pentraxins have also been implicated in develop-
mental synapse refinement, since in mice lacking both NP1
and Narp, retinal ganglion cell axons fail to show normal eye-
specific segregation at early ages (P10) (Bjartmar et al., 2006).
It is possible that neuronal pentraxins mark synapses for degra-
dation, in a manner analogous to their function in the innate
immune system. Of note, some nonneuronal pentraxins can
bind directly to C1q, resulting in either inhibition or activation
of the classical complement cascade, depending on the
context (Nauta et al., 2003). If neuronal pentraxins interact
with C1q, which remains to be determined, the lack of remod-
eling in both C1q- and neuronal pentraxin-deficient mice could
potentially reflect a failure of a late stage in remodeling in whichNeuron 64, October 15, 2009 ª2009 Elsevier Inc. 97
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tosed through a single, immune-like mechanism. However, there
are significant differences in both the timing and magnitude of
the remodeling deficit in C1q- versus neuronal pentraxin-defi-
cient mice: for example, loss of neuronal pentraxin causes a
larger-magnitude deficit in eye-specific segregation that resolves
by P30, while loss of C1q causes a smaller deficit that is attenu-
ated but still measurable at P30 (Bjartmar et al., 2006; Stevens
et al., 2007). In the future, it will be important to determine if
neuronal pentraxins and C1q contribute to synapse remodeling
via partially or fully mechanistically distinct processes.
Glutamatergic transmission was absent in cultured retinal
ganglion cells from neuronal pentraxin mutants, while ganglion
cell activity was elevated in intact retinas (Bjartmar et al.,
2006), suggesting that these proteins may affect refinement indi-
rectly, by modifying the activity that drives it. In contrast, both
MHCI-deficient and C1q-deficient animals show normal retinal
waves (Huh et al., 2000; Stevens et al., 2007), suggesting they
do not fail to generate the activity that drives remodeling but
rather are unable to translate it into appropriate activity-depen-
dent changes in connectivity.
Immune Proteins as Regulators of Basal
Synaptic Transmission
A number of immune proteins have been detected at mature
synapses (Boulanger et al., 2001), and some have been found
to regulate synaptic transmission (Table 2). A prominent example
is the proinflammatory cytokine TNFa. TNFa is released by glia,
and exogenous TNFa can promote the cell surface accumulation
Figure 3. Activity-Dependent Synaptic
Plasticity in Two Regions of the Adult
Mammalian CNS Requires Normal
Expression of MHCI
(A) MHCI protein (red) is expressed in dendrites
and colocalizes with PSD-95 (green) in hippo-
campal neurons in vitro. Scale bar, 10 mm. Modi-
fied with permission from Goddard et al. (2007),
copyright 2007 National Academy of Sciences,
USA. MHCI mRNA is also seen in CA1 pyramidal
cells (Figure 1A).
(B) Hippocampal frequency-dependent synaptic
plasticity is shifted in favor of potentiation in
MHCI-deficient (b2 m/TAP1/) or CD3z-defi-
cient mouse hippocampal slices. Reprinted with
permission from Huh et al. (2000).
(C) MHCI protein is expressed in Purkinje cell
dendrites and throughout the molecular layer.
Scale bar, 20 mm.
(D) The threshold for pairing-induced LTD at
parallel fiber-Purkinje cell synapses is reduced in
MHCI-deficient mice lacking the classical MHCI
genes Kb and Db (‘‘KO’’).
(C) and (D) modified with permission from McCon-
nell et al. (2009).
of AMPA-type glutamate receptors
(AMPARs) in hippocampal neurons
in vitro. Since AMPARs carry the majority
of excitatory glutamatergic current at
resting membrane potentials, this
TNFa-mediated increase in cell surface
AMPARs should regulate synaptic transmission, and indeed,
exogenous TNFa rapidly induces an increase in the frequency
and amplitude of miniature excitatory postsynaptic currents
(mEPSCs) in hippocampal neurons in vitro (Beattie et al., 2002;
Stellwagen et al., 2005). This result is consistent with a postsyn-
aptic increase in receptor sensitivity, which should increase both
mEPSC amplitude and frequency, as previously subthreshold
events are pulled out of the noise by more sensitive detectors.
Also consistent with a postsynaptic locus of action, TNFa affects
mEPSC frequency when applied postsynaptically, but not
presynaptically (Beattie et al., 2002). Endogenous TNFa is
required for maintenance of normal cell surface levels of
AMPARs, since application of a soluble form of the TNFa receptor
1 (sTNFR1), which acts as a TNFa antagonist, causes a drop in
cell surface AMPARs and a corresponding decrease in both the
frequency and amplitude of mEPSCs in hippocampal neurons
in vitro. Furthermore, this drop in AMPAR level is mimicked by
anti-TNFa antibodies. When applied to hippocampal slices,
sTNFR1 causes a drop in the AMPA/NMDA ratio, a drop in
AMPAR surface expression, and a drop and the frequency of
mEPSCs (Beattie et al., 2002; Stellwagen et al., 2005), all
suggesting a role for TNFa in maintaining AMPAR-mediated
transmission. In contrast to its facilitating effects on excitatory
synaptic transmission, exogenous TNFa decreases inhibitory
synaptic strength (Stellwagen et al., 2005), revealing that endog-
enous TNFa could potentially coordinate changes in excitation
and inhibition, for example, during synaptic scaling (see below).
In vitro and slice experiments in the mammalian hippocampus
indicate that MHCI regulates several features of presynaptic98 Neuron 64, October 15, 2009 ª2009 Elsevier Inc.
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Basal Synaptic Transmission
Manipulation Phenotype Reference
MHCI-deficient (b2 m–/–TAP–/–) mEPSC frequency increased, fEPSP amplitude normal Goddard et al., 2007; Huh et al., 2000
CD3z–/– fEPSP amplitude normal Huh et al., 2000
Exogenous TNFa mEPSC frequency increased, EPSP enhanced,
inhibition decreased, AMPA/NMDA ratio increased
Beattie et al., 2002; Stellwagen et al., 2005;
Stellwagen and Malenka, 2006
Soluble TNFR (sTNFR, TNFR1) mEPSC frequency decreased (in vitro, slices),
mEPSC amplitude decreased (in vitro only),
AMPA/NMDA ratio decreased
Beattie et al., 2002
TNFR–/– population spike/stimulus strength I/O function normal Albensi and Mattson, 2000nerve terminals at excitatory synapses. Cultured hippocampal
neurons from mice lacking most cell surface MHCI (b2 m/
TAP/) have slightly larger synapsin-immunoreactive presyn-
aptic puncta (Goddard et al., 2007). In apparent contrast,
another group found that treatment of cortical neurons in vitro
with antibodies against two specific MHCI proteins (anti-Kb or
anti-Db) reduced the number (but did not affect the size) of syn-
apsin puncta (Zohar et al., 2008). Thus, both studies agree that
changes in MHCI expression or function may modify synapsin
immunoreactivity, though they differ in terms of the parameters
affected (number versus size of synapsin puncta) and the sign
of the modification. This difference could be due to the cell types
used or the use of antibodies (which may have gain-of-function
effects by mimicking ligand binding) versus MHCI-deficient
transgenics.
Furthermore, MHCI-deficient hippocampal neurons in culture
have a higher frequency of mEPSCs, a parameter that is respon-
sive to changes in the presynaptic release of neurotransmitter,
and the size of glutamate vesicular transporter (vGlut)-immuno-
reactive puncta is increased. Electron micrographs of adult
hippocampal slices show that MHCI-deficient presynaptic termi-
nals contain 10% more synaptic vesicles (Goddard et al., 2007).
However, fEPSP amplitudes are normal in CA1 of the hippo-
campus of MHCI-deficient mice (Huh et al., 2000), arguing
against a blanket increase in the probability of glutamate release
in this circuit. Mice specifically lacking only the classical MHCI
proteins Kb and Db show enhanced presynaptic glutamate
release at climbing fiber (CF)-Purkinje cell (PC) synapses in the
cerebellum (McConnell et al., 2009). In contrast to the changes
in presynaptic parameters, two postsynaptic parameters are
normal in MHCI-deficient hippocampus: mEPSC amplitude,
which is responsive to changes in the expression or function of
postsynaptic glutamate receptors, and expression of the post-
synaptic scaffolding protein PSD-95 are both normal. These
results together suggest that MHCI selectively affects the basal
properties of the presynaptic terminal. It remains unknown if
these changes in presynaptic structure and function in MHCI-
deficient neurons are due to differences in the details of synapse
formation or elimination or rather reflect a later failure to homeo-
statically adjust presynaptic parameters in response to changing
postsynaptic activity during early development (see below).
Like changes in MHCI, changes in a component of some MHCI
receptors have been associated with regulation of glutamatergic
transmission. DAP12 is a transmembrane adaptor protein that isinvolved in signal transduction by a number of immunoreceptors,
including the natural killer (NK) cell receptors KIR2DS and
NKG2D, both of which bind to MHCI (Tomasello et al., 1998).
Although DAP12 is known for its role in activating NK cells, trans-
genic loss-of-function mutation of DAP12 reduces levels of GluR1
and GluR2 in the PSD fraction, increases the inward rectification
of synaptic AMPARs (Roumier et al., 2004), and increases the
AMPA/NMDA ratio (Roumier et al., 2008). Consistent with a role
for DAP12 in synaptic function, human mutations in DAP12 cause
a presenile dementia known as Nasu-Hakola disease (Paloneva
et al., 2000). Similarly, antibodies against the MHCI receptor
Ly49 increased the size of synapsin puncta, much like genetic
loss of MHCI, although Ly49 antibodies also increased the
number of synapsin puncta, which is unchanged in MHCI-defi-
cient neurons in vitro (Goddard et al., 2007; Zohar et al., 2008).
While MHCI clearly modifies some aspects of presynaptic
structure and function, it does not seem to be involved in deter-
mining the number of excitatory synapses in hippocampal
neurons in vitro, since average number of synapsin- or PSD-
95-immunoreactive puncta is unchanged in cultured MHCI-defi-
cient neurons (Goddard et al., 2007). In contrast, MHCI might
regulate synapse number in the developing LGN in vivo, since
activity-dependent retinal ganglion cell axon remodeling is
impaired in MHCI-deficient mice (Huh et al., 2000).
Mutant mice lacking the complement protein C1q show an
increase in the intensity of immunostaining for both the presyn-
aptic marker vGLUT2 and the postsynaptic marker PSD-95 in
the P16 lateral geniculate nucleus (LGN) (Stevens et al., 2007).
However, it remains to be determined if this is due to a change
in the expression of these markers at individual synapses, as is
seen in MHCI-deficient neurons (Goddard et al., 2007), or is
secondary to an increase in synapse number, perhaps due to
a failure of synapse elimination in the LGN at this age (Stevens
et al., 2007) (see above). Studies that further examine if immune
proteins regulate synapse number will need to take into account
the fact that synapse counts from a snapshot at a single devel-
opmental time point are the product of both synapse formation
and synapse elimination. This is particularly important since
MHCI and C1q/C3 both modify synapse elimination in some
projections (Huh et al., 2000; Stevens et al., 2007).
In addition to its regulation of the properties of excitatory
connections, MHCI was recently identified in a screen for targets
of the transcription factor Npas4, which controls the number of
inhibitory GABA-releasing synapses that contact excitatoryNeuron 64, October 15, 2009 ª2009 Elsevier Inc. 99
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ReviewTable 3. Effects of Specific Immune Proteins on Acute and Homeostatic Synaptic Plasticity in the Adult Mouse Hippocampus
Synaptic Plasticity
HFS-LTP
Manipulation Phenotype Reference
MHCI-deficient (b2 m–/–TAP–/–) LTP enhanced Huh et al., 2000
CD3z–/– LTP enhanced Huh et al., 2000
Exogenous IL-6 LTP inhibited, PTP inhibited Tancredi et al., 2000
Exogenous TNFa LTP inhibited Tancredi et al., 1992;
but see Stellwagen and Malenka, 2006
TNFR–/– LTP normal Albensi and Mattson, 2000
TNFa–/– LTP normal Stellwagen and Malenka, 2006
LFS-LTD
MHCI-deficient (b2 m–/–TAP–/–) LTD abolished Huh et al., 2000
CD3z–/– LTD abolished Huh et al., 2000
TNFR–/– LTD impaired Albensi and Mattson, 2000;
but see Stellwagen and Malenka, 2006
TNFa–/– LTD normal Stellwagen and Malenka, 2006
Homeostatic Plasticity: Reduced Activity (TTX)
MHCI-deficient (b2 m–/–TAP–/–) no increase in mEPSC amplitude,
no increase in PSD-95 puncta size,
nor further increase in synapsin
immunoreactivity (occluded?)
Goddard et al., 2007
TNFa–/– no increase in mEPSC amplitude Stellwagen and Malenka, 2006
Soluble TNFR no increase in mEPSC amplitude,
no decrease in mIPSC amplitude
Stellwagen and Malenka, 2006
Homeostatic Plasticity: Increased Activity (Picrotoxin)
TNFa–/– normal decrease in mEPSC amplitude Stellwagen and Malenka, 2006
HFS-LTP, high-frequency-stimulation-induced long-term potentiation; LFS-LTD, low-frequency-stimulation-induced long-term depression.neurons (Lin et al., 2008). However, it remains unknown if MHCI
affects the establishment, maintenance, or function of
GABAergic connections. A number of proinflammatory cyto-
kines, including IL-1b (Zeise et al., 1992) and TNFa (Stellwagen
et al., 2005), have been shown to regulate inhibitory synaptic
transmission.
Immune Proteins in Structural and Functional Plasticity
of Synapses
In addition to their role in the establishment of appropriate
connectivity and synaptic properties, several immune proteins
have been implicated in the later structural and functional plas-
ticity of synapses. This includes developmental plasticity (e.g.,
the activity-dependent elimination of developing synapses, see
above), as well as modification of the efficacy of mature
synapses. Plasticity at all ages falls into two broad categories:
acute, synapse-specific forms of associative plasticity (e.g.,
LTP and LTD), which are thought to contribute to synapse refine-
ment and learning and memory (Kessels and Malinow, 2009),
and slower, more global forms of nonassociative plasticity that
arise in response to chronic changes in activity (homeostatic
plasticity or synaptic scaling), which are thought to stabilize
neuronal networks. These two forms of plasticity likely go
hand-in-hand in most circuits, since LTP and LTD can easily
saturate synaptic transmission and destabilize networks without
homeostatic compensation (Turrigiano, 2008). Intriguingly, some100 Neuron 64, October 15, 2009 ª2009 Elsevier Inc.of the same immune proteins are required for both acute and
homeostatic plasticity in the developing and adult brain, sug-
gesting that they are part of a shared mechanistic program for
plasticity that operates on very different timescales.
Acute Synaptic Plasticity
Immune proteins have been implicated in the functional plasticity
of mature synapses (Table 3). MHCI is required for normal
activity-dependent synaptic plasticity in both the adult hippo-
campus (Huh et al., 2000) and adult cerebellum (McConnell
et al., 2009) (Figures 3B and 3D). MHCI protein is expressed in
the dendrites of hippocampal neurons in vitro (Goddard et al.,
2007), and in hippocampal slices from mice lacking cell surface
MHCI, LTP induced by tetanic stimulation is approximately twice
the magnitude of that induced in WT. Plasticity induced by lower-
frequency stimulation is also affected: LTD in response to 1 Hz or
0.5 Hz stimulation is abolished in MHCI-deficient hippocampus
(Huh et al., 2000), although it remains unknown if LTD could be
induced in these mutants at even lower stimulation frequencies.
Thus, endogenous MHCI in the adult hippocampus inhibits LTP
and either permits or promotes LTD. A component of many
MHCI immunoreceptors, CD3z, is also required for LTD and
limits LTP in the adult hippocampus (Huh et al., 2000) (Figure 3B).
Transgenic mice lacking another immunoreceptor component,
DAP12, have enhanced pairing-induced hippocampal LTP
(Roumier et al., 2004), although their responses to tetanic stimu-
lation have not yet been determined.
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abolished in mice lacking the TNF receptor (Albensi and Matt-
son, 2000), and exogenous TNFa may inhibit LTP (Tancredi
et al., 1992), indicating that TNFa, like MHCI, could inhibit LTP
and either permit or promote LTD (Table 3). The inconsistencies
in the results to date could be due to differences in experimental
measures (for example, some studies monitored the slope of the
fEPSP, while others monitored the amplitude of the population
spike) or may indicate that TNFa is not part of the core mecha-
nism of LTP or LTD, but instead modifies the threshold for the
induction of some forms of plasticity. Since TNFa is a proinflam-
matory cytokine and can regulate MHCI expression, any effects
TNFa may have on plasticity could potentially be mediated by
changes in MHCI. In fact, several other proinflammatory cyto-
kines, including interleukin- (IL-) 6 (Bellinger et al., 1995; Li
et al., 1997; Tancredi et al., 2000), IL-1b (Cunningham et al.,
1996; Katsuki et al., 1990), IL-2 (Tancredi et al., 1990), IL-18
(Curran and O’Connor, 2001), IL-8 (Xiong et al., 2003), and inter-
feron-a and -b (D’Arcangelo et al., 1991; Mendoza-Fernandez
et al., 2000), also inhibit hippocampal LTP, consistent with the
possibility they may converge on a common pathway. Although
exogenous IL-6 inhibits LTP in hippocampal slice, IL-6 levels are
dramatically upregulated by LTP induction in vivo (Balschun
et al., 2004; Jankowsky et al., 2000), and application of an anti-
IL-6 antibody 90 min after tetanus prolonged LTP and improved
long-term memory (Balschun et al., 2004).
MHCI and its receptors have also been implicated in synaptic
plasticity in the adult cerebellum. The classical MHCI molecules
H2-Kb and H2-Db are normally expressed in cerebellar Purkinje
cells (PCs), and in Kb/Db/ mice, the threshold for LTD at
parallel fiber (PF)-PC synapses is reduced (Figures 3C and 3D),
although the extent of LTP induced at these synapses is normal.
In addition, climbing fiber (CF)-PC paired-pulse facilitation (PPF)
is enhanced in these animals. Kb/Db/ mice also perform
better on the rotarod, a behavioral test that is thought to require
plasticity in the cerebellum; they learn the task more effectively
and remember it for longer, suggesting the MHCI-dependent
change in cerebellar plasticity may have functional conse-
quences (McConnell et al., 2009). PF-PC PPF (but not CF-PC
PPF) is enhanced in mice lacking CD33, an invariant subunit of
the T cell receptor (TCR), and rotarod performance is impaired
in these mice (Nakamura et al., 2007), in contrast to what is
seen in Kb/Db/ mice.
Proteins of the innate immune system have also been impli-
cated in long-term functional plasticity in invertebrates. For
example, at mature Aplysia synapses, blockade of Dscam
either pre- or postsynaptically interferes with the redistribution
of glutamate receptors in response to serotonin treatment,
which is likely the cause of the observed impairment of sero-
tonin-induced long-term facilitation (LTF) after Dscam blockade
(Li et al., 2009).
Adult Plasticity in the Mammalian Visual Cortex
Activity-dependent functional plasticity is thought to underlie
many examples of activity-dependent structural plasticity of the
mature CNS, and in support of this model, some of the same
immune molecules have been implicated in both processes.
The role of immune molecules in adult structural plasticity has
primarily been characterized in the mammalian visual cortex(Table 1). In this system, loss of visual input to one eye—due to
monocular deprivation or enucleation—is associated with a
weakening and pruning of inputs from the deprived eye as well
as a gradual strengthening and expansion of inputs from the
open eye (Mioche and Singer, 1989; Shatz and Stryker, 1978;
Wiesel, 1982; Wiesel and Hubel, 1965). TNFa is not required for
the weakening of inputs from the deprived eye but is essential
for the later strengthening of open eye inputs (Kaneko et al.,
2008). It is proposed that this strengthening is a homeostatic
response to the earlier, competitive weakening of deprived-eye
inputs, implying that TNFa may be required for some forms of
homeostatic plasticity (see below). An MHCI-binding protein,
PIRB, has also been implicated in deprivation-induced plasticity
in the mammalian visual cortex. In mice expressing a form of PIRB
in which the transmembrane domain has been removed, prevent-
ing PirB-mediated intracellular signaling (PIRB-TM mice), the
deprivation-induced expansion of the open eye’s territory is
more robust and can be induced well after the close of the devel-
opmental critical period (Syken et al., 2006). While the depression
of responses to the closed eye was not examined in PIRB-TM
mice, this result suggests that PIRB may limit the same process
that TNFa enhances, that is, the delayed, homeostatic strength-
ening of connections from the open eye.
Homeostatic Plasticity (Synaptic Scaling)
In hippocampal neurons in vitro, chronic, long-term reduction of
excitatory synaptic activity (e.g., with tetrodotoxin [TTX]) nor-
mally causes an increase in synaptic transmission, while a
chronic increase in activity (e.g., by application of picrotoxin,
a blocker of GABAA-mediated inhibition) causes a decrease in
synaptic transmission. These changes keep the activity of
networks relatively constant in the face of ongoing acute plas-
ticity, keeping excitation and inhibition in balance and preventing
runaway excitation that can lead to epileptic activation and exci-
totoxicity (Turrigiano, 2008). Although the molecular mecha-
nisms underlying homeostatic plasticity remain largely unknown,
it is notable that TNFa and MHCI, both immune proteins, are two
of only a handful of molecules that have been implicated in
activity-dependent synaptic scaling (Table 3).
One important prediction regarding molecular mediators of
homeostatic plasticity is that they should be regulated in
response to long-term changes in network activity. Indeed,
blocking activity with TTX reduces the expression of MHCI in
the prenatal LGN in vivo (Corriveau et al., 1998) and in hippo-
campal neurons in vitro (Goddard et al., 2007), while increasing
activity with kainic acid increases MHCI expression in the den-
tate gyrus in vivo (Corriveau et al., 1998). Thus, MHCI is bidirec-
tionally regulated by changes in activity, with increases in activity
adding to the normal constitutive expression of MHCI. In
contrast, TNFa may be released in response to a drop in activity
(Stellwagen and Malenka, 2006). The activity-dependent avail-
ability of these factors, both of which regulate synaptic transmis-
sion and plasticity (see above), may provide a mechanism for
homeostatic modifications.
In support of this possibility, MHCI and TNFa are both required
for synaptic scaling. In WT hippocampal neurons in vitro, chronic
TTX treatment causes an increase in both presynaptic synapsin
and postsynaptic PSD-95 immunoreactivity. In MHCI-deficient
neurons, however, neither synapsin nor PSD-95 scale up inNeuron 64, October 15, 2009 ª2009 Elsevier Inc. 101
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that synapsin-immunoreactive puncta are already enlarged prior
to TTX treatment in MHCI-deficient neurons, suggesting that
presynaptic scaling may be occluded by prior saturation of syn-
apsin expression. Postsynaptic PSD-95, however, is indistin-
guishable from WT at rest, and therefore the failure of PSD-95
immunoreactivity to scale up in response to TTX likely reflects
a requirement for MHCI in postsynaptic homeostatic plasticity.
TNFa has also been implicated in the homeostatic plasticity
of postsynaptic parameters. Conditioned medium from TTX-
treated cultures is sufficient to increase synaptic AMPAR levels
and mEPSC amplitude, indicating that a soluble factor released
by TTX-treated cells is sufficient to transfer these forms of
scaling from one culture to another. This factor may be secreted
TNFa, since acute application of TNFa alone increases AMPAR
levels at the cell surface in a manner that mimics TTX (Beattie
et al., 2002; Stellwagen et al., 2005). More tellingly, soluble
TNFR, which scavenges endogenous TNFa, blocks the ability
of conditioned medium or TTX treatment to induce scaling of
AMPARs and mEPSCs. This suggests that TNFa released into
the culture medium during activity blockade is required for the
homeostatic delivery of AMPARs to the cell surface. sTNFR
also prevents the decrease in the amplitude of miniature inhibi-
tory postsynaptic currents (mIPSC) caused by TTX, revealing
that TNFa mediates scaling of both excitation and inhibition in
response to TTX. However, TNFa does not mediate the reduc-
tion in excitatory synaptic strength produced by increased
neuronal activity, suggesting that while TNFa is required for
scaling up of excitatory synapses, other factors are responsible
for scaling them down (Stellwagen and Malenka, 2006).
Homeostatic synaptic scaling could occur in a cell-autono-
mous manner to maintain a steady level of overall synaptic drive
in the face of input-specific plasticity, or could be driven by func-
tional matching of pre- and postsynaptic elements at individual
synaptic contacts. TNFa-mediated scaling is not cell-autono-
mous, since glia are the source of endogenous TNFa that drives
scaling in neurons (Beattie et al., 2002). It is tempting to specu-
late that MHCI might be involved in coordinating pre- and post-
synaptic properties, since presynaptic synapsin puncta are
enlarged, but postsynaptic PSD-95 puncta are unaffected, in
MHCI-deficient neurons (Goddard et al., 2007), indicating an
unusual uncoupling of pre- and postsynaptic parameters.
Plasticity in Response to Neuronal Injury
In many regions of the adult CNS, nerve transection, crush, or
lesion is followed by a secondary loss of inputs onto the cell
body and dendrites of the damaged cell (synaptic stripping).
This retrograde wave of synapse loss may represent a form of
homeostatic plasticity or may involve the inappropriate reactiva-
tion of mechanisms of developmental synapse elimination.
Indeed, immune molecules that are involved in normal, develop-
mental synapse elimination and homeostatic plasticity have also
been implicated in injury-induced plasticity. One week after
peripheral transection of sciatic motoneurons, significant
detachment of inputs onto the cell body of the axotomozed moto-
neuron is normally observed. In mice lacking either b2 m or TAP,
both of which have reduced levels of MHCI on the cell surface,
synaptic stripping is enhanced in vivo. Thus, endogenous MHCI
minimizes secondary synapse loss after injury in this model. Of102 Neuron 64, October 15, 2009 ª2009 Elsevier Inc.note, the neuroprotective effect of MHCI is relatively selective
for axon terminals that, based on morphological criteria, are puta-
tively inhibitory (Oliveira et al., 2004). This MHCI-mediated pres-
ervation of inhibitory terminals might prevent further synapse loss
by reducing the risk of excitotoxicity.
In this same injury model, later regeneration of the axotomized
neurons themselves is also slightly impaired in MHCI-deficient
animals (Oliveira et al., 2004). This is interesting in light of the
fact that one MHCI receptor, PIRB, has recently been found to
mediate some of the regeneration-inhibiting effects of myelin-
derived proteins on cerebellar granule neurons in vitro (Atwal
et al., 2008). Thus, MHCI is required for the small basal level of
axonal regeneration, while PIRB, a putative MHCI receptor, is
required for the opposing inhibition of regeneration. There are
several possible explanations for this apparent contrast. Mech-
anisms of regeneration may vary for different cell types in vitro
versus in vivo; MHCI may inhibit constitutive, regeneration-inhib-
iting signaling by PIRB; or PIRB and MHCI may function indepen-
dently to regulate regeneration. Peripheral nerve regeneration
can also be inhibited by IL-1 receptor antagonists (Guenard
et al., 1991), indicating that endogenous IL-1, like MHCI,
promotes nerve regeneration after injury. These results all point
to potential mechanisms whereby inflammatory signaling may
regulate synapse loss and regeneration following nerve injury.
The contributions of brain immune molecules in disease
pathogenesis and progression, injury responses, and pain are
discussed in detail elsewhere in this issue. Clearly, immune
responses to neuronal injury and disease can cause neuroin-
flammation and/or autoimmunity (see Bhat and Steinman, 2009
[this issue of Neuron]) and thereby exacerbate damage.
However, the fact that immune proteins also have normal func-
tions in brain development and plasticity adds two novel, nonim-
mune dimensions to their potential role in pathogenic processes.
First, changes in the expression or function of immune proteins
could lead to interruption of their normal functions in brain devel-
opment and plasticity (loss of function), potentially disrupting the
establishment and modification of brain circuitry. For example,
high levels of circulating proinflammatory cytokines during infec-
tion and inflammation lead to sickness behavior, including dete-
rioration of cognition. Elevated cytokine levels could potentially
contribute to changes in cognition by disrupting their normal
function in the forms of synaptic plasticity thought to underlie
some forms of learning and memory (Balschun et al., 2004).
Second, altered expression or activation of these proteins
could lead to inappropriate reactivation of their normal brain
functions (gain of function). Immune proteins that are essential
for the normal developmental pruning and elimination of
synapses (e.g., C1q, MHCI) are upregulated in some disease
states, and aberrant re-expression of these proteins could
contribute to pathological synapse loss. For example, C1q is
expressed at low levels in the adult retina, but is re-expressed
in a mouse model of glaucoma (Stevens et al., 2007). Similarly,
neuronal MHCI is upregulated with age in some cell populations
(Edstrom et al., 2004), and reactivation of MHCI-dependent
synapse remodeling and synaptic plasticity (Huh et al., 2000)
could contribute to age-related synapse loss, as well as to
changes in synaptic plasticity that could give rise to age-related
memory impairments. Thus determining how immune proteins
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novel immune-mediated features of a wide variety of neuropath-
ological states.
Search for Cellular Mechanisms
An outstanding question is how, on a molecular level, immune
proteins perform their nonimmune functions in the development
and plasticity of the brain. While in most cases a great deal is
known about immune protein signaling pathways in cells of the
immune system, almost nothing is known yet about how these
proteins receive, transduce, or respond to signals in neurons.
Immune Signaling Cascades in the Brain
One possibility is that these proteins use signaling mechanisms
in the brain that are either similar or identical to those employed
in the immune system, with either related or distinct outcomes.
Such immune signaling mechanisms may be cell-autonomous
within a single neuron, or may involve interactions with other
neurons or glia. Fortunately, the experimental tools (e.g., trans-
genics, antibodies, constructs) used to study these proteins in
the immune system are ready-made to test these possibilities
in the brain.
To date, there is preliminary evidence that similar signaling
cassettes may be used by some proteins in both the nervous
and immune systems. For example, activity-dependent synaptic
remodeling is similarly impaired in mice lacking either C1q, the
initiating protein in the complement cascade, or C3, a down-
stream component, suggesting that C1q may affect remodeling
through interactions with other proteins of the complement
cascade. Strikingly, the function of C1q and C3 in the brain
also appears functionally analogous to their function in the
immune system: the clearance of cellular material that has
been marked for destruction (Stevens et al., 2007). Outside the
brain, the complement cascade trigger assembly of the mem-
brane attack complex (MAC), which leads to cell lysis. It remains
to be determined if the MAC is involved in the removal of inappro-
priate axons in the developing visual system. Outside the CNS,
complement-mediated attack is targeted to damaged or foreign
cells by a large number of highly specific triggers and regulators.
It is unclear if complement is as selectively targeted in the
nervous system. Some C1q is detected in areas where pre-
and postsynaptic markers are not apposed in the developing
LGN, putatively sites of either nascent or degenerating synapses
(Stevens et al., 2007). If C1q is indeed enriched at synapses that
have been tagged for removal, it will be important to identify the
regulatory proteins that underlie this specificity and attract
complement proteins to these synapses and not their neighbors.
PIRB is another immune protein that may use overlapping
signaling pathways in the immune system and the nervous
system. PIRB an immunoreceptor that is phosphorylated in
immune cells upon ligand binding, triggering recruitment of the
downstream phosphatases Shp-1 and Shp-2. PIRB isolated
from brain is also phosphorylated, and is associated with
Shp-1 and Shp-2 (Syken et al., 2006), suggesting that these
immunoreceptors may employ at least some of the familiar
immune signaling cascade in neurons. However, it is unknown
if this phosphorylation and subsequent recruitment of Shp phos-
phatases is required for PIRB’s effects on brain development
and responses to neuronal injury.PIRB is one of many receptors for MHCI. MHCI proteins have
small intracellular domains and, in their immune capacity, bind to
cell surface and/or soluble proteins to generate their cellular
effects. Dozens of receptors for classical and nonclassical
MHCI proteins have been identified outside the nervous system
(e.g., Natarajan et al., 2002). It is possible that neuronal MHCI
can bind to one or more of these classical immunoreceptors
expressed on the surface of CNS cells. Several lines of evidence
support this possibility. First, immunoreceptors that bind to
MHCI have been detected in neurons (Figure 1), including mouse
PIRB (Atwal et al., 2008; Syken et al., 2006), KIR-like genes (Bry-
ceson et al., 2005), members of the mouse Ly49 family (Zohar
et al., 2008), the invariant TCR subunits CD3z (Barco et al.,
2005; Huh et al., 2000) and CD33 (Nakamura et al., 2007), and
mRNA encoding unrearranged TCRb chain (Nishiyori et al.,
2004; Syken and Shatz, 2003). Second, not only are these recep-
tors expressed, but at least one, PIRB, binds to neurons in
a manner that is responsive to MHC levels (Syken et al., 2006).
Third, knockouts of specific immunoreceptor proteins pheno-
copy some of the effects of loss of MHCI. For example, retinoge-
niculate remodeling is similarly impaired in MHCI-deficient and
CD3z-deficient mice, suggesting that MHCI may regulate this
remodeling via a CD3z-containing receptor (Huh et al., 2000).
Similarly, antibodies against either the MHCI proteins Kb and
Db or the MHCI receptor Ly49 have effects on neuron survival
and neurite outgrowth in cortical neurons in vitro; however, the
two antibodies have opposite effects, with anti-MHCI promoting
outgrowth and reducing survival, and anti-Ly49 reducing
outgrowth and enhancing survival (Zohar et al., 2008).
Despite the detection of several MHCI receptors in the CNS,
recent experiments suggest that additional mediators of MHCI
and immunoreceptor functions in the nervous system remain
to be identified. For example, although retinogeniculate remod-
eling is impaired in MHCI-deficient mice (Huh et al., 2000), retino-
geniculate remodeling is normal in mice lacking functional PIRB
(Syken et al., 2006), indicating that MHCI binding to PIRB is not
required for normal remodeling of these projections. In fact,
although MHCI and PIRB are coexpressed in neurons, and
MHCI affects PIRB binding to neurons, there is little evidence
to date that the known effects of MHCI on brain development
or plasticity are mediated by this immunoreceptor, since
MHCI-deficient animals and PIRB-TM animals do not share
any published phenotypes (see Tables 1–3). Conversely, there
are hints that neurons may express other ligands for PIRB, since
genetic ablation of MHCI reduces, but does not eliminate, the
saturable binding of alkaline phosphatase-labeled PIRB to the
cell surface of either mouse embryo fibroblasts or cultured
cortical neurons (Syken et al., 2006). Further experiments (e.g.,
examining hippocampal LTP and LTD in PIRB-TM mice, and
examining visual cortical plasticity in MHCI-deficient mice) will
help clarify the molecular relationships between MHCI and the
multiple immunoreceptors expressed in neurons.
Immune proteins may participate in signaling cascades that
are composed of the same molecular players as in the immune
system, but respond differently to modulatory cues, and have
very different readouts, in neurons. For example, TNFa is a proin-
flammatory cytokine that causes upregulation of MHCI in non-
neuronal cells, but instead causes downregulation of MHCINeuron 64, October 15, 2009 ª2009 Elsevier Inc. 103
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et al., 2006). Thus, although TNFa is a regulator of MHCI expres-
sion within and outside the CNS, at least at early ages, the sign of
the regulation differs. Similarly, mGluR5 is expressed in T cells,
but unlike in neurons, where mGluR5 activation is usually
coupled to phospholipase C (PLC) (Pin and Duvoisin, 1995),
mGluR5 is coupled to stimulation of adenylate cyclase in
T cells (Pacheco et al., 2004).
The idea that immune proteins in the brain may employ clas-
sical immune signaling cascades makes it relevant to consider
that many of these molecules converge on shared signaling
pathways in the immune response, and may do so in the brain
as well. MHCI in neurons and astrocytes can be regulated by
TNFa (Lavi et al., 1988; Neumann et al., 1997; Sourial-Bassillious
et al., 2006), raising the possibility that some of the effects of
TNFa could be mediated by changing MHCI levels in neurons.
Consistent with this possibility, LTD is abolished in mice lacking
either the TNF receptor (Albensi and Mattson, 2000) or cell
surface MHCI (Huh et al., 2000), and exogenous TNFa inhibits
LTP (Tancredi et al., 1992), while loss of MHCI promotes LTP
(Huh et al., 2000). The possible role of MHCI in mediating these
effects of TNFa could be tested by examining LTP and LTD after
applying TNFa to MHCI-deficient neurons. However, not all of
the effects of TNFa are likely mediated by MHCI, since TNFa
modifies AMPAR trafficking and AMPAR-mediated currents
(Beattie et al., 2002), while changes in MHCI levels do not affect
basal excitatory fEPSP amplitude, which is primarily AMPAR-
mediated at resting membrane potentials (Huh et al., 2000). Acti-
vation of the complement cascade can indirectly regulate MHCI
expression outside the CNS, and loss of either C1q, C3 (Stevens
et al., 2007), or MHCI (Huh et al., 2000) alone can each impair
retinogeniculate remodeling. Again, it is as yet unknown if these
molecules act in a single common pathway, or have parallel,
potentially additive effects on remodeling at these synapses.
Novel, Nonimmune Pathways
In addition to acting through familiar binding partners and signal
transduction pathways, it is also possible that immune proteins
have neuronal effects through novel interactions with proteins
that have no known immune function. A precedent for nonimmu-
nological binding partners for MHCI has been identified outside
the nervous system. X-ray crystallography has demonstrated
that the MHCI-like protein HFE can bind to the dimeric transferrin
receptor (TfR), an interaction that regulates TfR function and iron
homeostasis. Disruption of this normal interaction between HFE
and the TfR is the likely cause of the common iron-loading
disorder hereditary hemochromatosis (Bennett et al., 2000).
Studies of a particular nonclassical MHCI, M10, are also consis-
tent with non-immune-protein interactions for MHCI in neurons.
M10 proteins appear to be expressed exclusively in neurons of
the mammalian vomeronasal organ (VNO), where they associate
with V2R pheromone receptors and are required for normal
delivery of V2Rs to the dendritic tips of VNO sensory neurons.
In mice lacking most if not all cell surface MHCI proteins, phero-
mone-mediated behavior is impaired, suggesting that MHCI-
dependent V2R trafficking is required for normal pheromone
sensing in vivo (Ishii et al., 2003; Ishii and Mombaerts, 2008;
Loconto et al., 2003). It has further been proposed that MHCI-
associated peptides may function as chemosensory signals104 Neuron 64, October 15, 2009 ª2009 Elsevier Inc.(Leinders-Zufall et al., 2004). MHCI is known to bind to a wide
array of cell surface and soluble proteins and peptides outside
the CNS, and it seems likely that a similar diversity of protein inter-
actions with MHCI is exploited for distinct functions in the brain.
Diversity and Specificity of Signaling
A tantalizing feature of many proteins of the immune system is
their remarkable diversity. Different immune proteins generate
diversity at many levels, including large gene families, somatic
recombination, alternate mRNA splicing, high allelic diversity,
and the binding to diverse peptides. In the immune system, at
least some of this diversity is harnessed for a complex and
precise molecular recognition system, but for the most part it
remains unknown if this diversity is exploited in the neuronal
functions of immune proteins. For example, vertebrate TCRs
undergo somatic recombination to form a virtually unlimited
repertoire of receptors, which permits precise, specific recogni-
tion of small MHCI-presented peptides that differ by only a few
amino acids. Similarly, members of the MHCI family are among
the most polymorphic in the genome, with hundreds of possible
alleles, with each allele conferring the ability to present and
thereby recognize different populations of peptides. The binding
of MHCI-presented peptides to somatically recombined TCRs
permits tremendous diversity and specificity of protein interac-
tions. However, it remains unknown if MHCI presents peptides
on the surface of neurons, and if so, if the identity of these
peptides affects the neuronal functions of MHCI. In Drosophila,
Dscams can undergo alternate splicing to produce thousands
of distinct transcripts, and recent studies suggest at least
some of this diversity is important for neuronal intercellular
recognition events during brain development (Chen et al.,
2006; Hattori et al., 2007). Intriguingly, although DSCAM does
not appear to undergo alternative splicing in mammals, there is
evidence that it is still able to participate in molecular recognition
events between neurons (Fuerst et al., 2008), though the mech-
anism remains unclear.
In contrast to TCRs, some Ly49 receptors and the leukocyte
immunoglobulin-like receptors (LILR) -B1 and -B2 interact with
MHCI proteins relatively promiscuously, with little or no speci-
ficity for particular MHCI alleles, genes or MHCI-associated
peptides (Natarajan et al., 2002). Both precise and promiscuous
forms of molecular recognition might have a place in the devel-
oping and adult brain; for example, diverse, specific molecular
interactions could be involved in the establishment of appro-
priate neuronal connectivity, while promiscuous interactions
could help ensure that basic cellular events in development
and plasticity occur normally in the face of massive allelic,
peptide, or mRNA splicing variability. MHCI proteins are able
to participate in both precise (e.g., presented antigenic peptide)
and relatively promiscuous (e.g., CD8) interactions by using
different regions of the protein to mediate binding to diverse
versus static partners. It will be of interest to determine if immune
proteins also spatially segregate the domains used for their
neuronal and immunological functions, thereby allowing them
to be shaped by potentially antagonistic evolutionary pressures.
Future Directions and Conclusions
For many of the immune proteins mentioned here, a careful
examination of neuronal mRNA and protein expression patterns
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mental expression patterns may provide important clues to the
function of specific immune proteins. There is some evidence
that overall developmental changes in immune protein expres-
sion may differ in the CNS as compared to the periphery. For
example, while MHCI is downregulated in the periphery with
age (a change that is thought to contribute to peripheral immuno-
scenescence, or breakdown of the immune response), in the
CNS the opposite is seen: MHCI levels, which are relatively low
in the uninfected adult CNS, increase with age (e.g., Edstrom
et al., 2004). For diverse protein families, such as MHCI and
Ly49, an important clue about the functional role of this diversity
in neurons will be to determine how the members differ in their
expression, and if more than one member can be expressed
by a single cell. In some cases, these studies will require the
development of new antibodies against fix-insensitive epitopes
or against neuron-specific isoforms of immune proteins. Simi-
larly, reagents need to be developed to reliably discriminate
the many members of large immune protein families such as
the MHCI proteins, the Ly49 receptors, and the Dscams, which
are comprised of dozens to thousands of members. These
reagents will help build a more complete picture of the functions
of these proteins in normal development and plasticity, and allow
semi-quantitiative evaluation of changes in immune protein
expression in the context of disease states and injury.
A second, related area in need of attention is the regulation of
expression of these immune proteins in the context of the
nervous system. Although much is known about the regulation
of immune proteins in the periphery during inflammation, rela-
tively little is known about how these proteins are regulated in
neurons, particularly under nonpathological conditions. Neu-
ronal expression of MHCI is dynamic during brain development
and is spatially restricted throughout life (Corriveau et al., 1998;
Huh et al., 2000), and this tight regulation may be important to
its neuronal functions. Regulation of immune protein expression
in neurons may also be necessary in order to minimize potentially
destructive engagement of these molecules in the brain during
the course of their immune functions. In particular, control of
the cell surface population of MHCI proteins may be critical for
both its normal neuronal functions and avoidance of pathological
engagement of its immune functions, leading to autoimmunity.
Neuronal MHCI is regulated by increases and decreases in elec-
trical activity (Corriveau et al., 1998; Neumann et al., 1995) and
by the neuronal transcription factors CREB (Barco et al., 2005),
Npas4 (in inhibitory neurons) (Lin et al., 2008), and MeCP2 (in
the neuron-derived cell line N2A) (Miralves et al., 2007), revealing
that the level and pattern of MHCI expression can be responsive
physiologically relevant neuronal cues.
In addition to these novel neuronal regulators, it is also of
interest whether MHCI and other polyfunctional immune proteins
retain their responsiveness to classical inflammatory cues. If so,
immune signaling in the periphery could trigger changes in
neuronal expression of these molecules, and thereby impact
brain development and plasticity. MHCI expression in the CNS,
as in the periphery, is regulated by pro- and antiinflammatory
cytokines (e.g., Fujimaki et al., 1996; Linda et al., 1998; Neumann
et al., 1995, 1997; Wong et al., 1984, 1985). However, it remains to
be determined if the sign and magnitude of the regulation differin neurons or if regulation varies with developmental age or
CNS cell type, although preliminary evidence suggests this may
be the case (Edstrom et al., 2004; Sourial-Bassillious et al.,
2006). Cytokines are regulated by a variety of insults, including
ischemia (Amantea et al., 2009) and maternal immune challenge
(see Deverman and Patterson, 2009 [this issue ofNeuron]), raising
the possibility that cytokine-driven changes in MHCI and other
immune effectors may mediate some effects of these insults on
the developing and adult brain. Similarly, MHCI is upregulated
in neurons following injury (i.e., facial or sciatic nerve transaction)
(Maehlen et al., 1989; Streit et al., 1989; Zanon and Oliveira,
2006), and the presence of MHCI at the cell surface helps limit
postinjury synapse loss and may promote regeneration (Oliveira
et al., 2004). Molecular crosstalk between immune and neuronal
signaling, mediated by pleiotropic molecules that function in both
systems, may contribute to the pathogenesis and progression of
both neurodevelopmental and neurodegenerative disorders.
Thus understanding how immune proteins are regulated by
inflammatory signals will provide important clues to how periph-
eral immune signaling may affect brain structure and function.
Just as it is important to identify upstream regulators of
immune proteins in the brain, it is essential to identify their down-
stream effectors. This third area of active research involves
determining the cellular and molecular mechanisms whereby
these immune proteins perform their nonimmunological func-
tions in the brain. This research can use as a starting point
what is known about the downstream signaling of these proteins
in the immune system. However, unbiased screen-based exper-
iments will also be important for the discovery of novel, neuron-
specific signaling pathways for immune proteins in the brain.
One exciting feature of the study of pleiotropic proteins is that
findings about one function can provide insight into the mecha-
nisms of other functions. For most of the molecules discussed
here, including MHCI, classical MHCI immunoreceptors,
complement, and cytokines, immune functions are far better-
characterized than neuronal functions. For these molecules,
their relatively extensive immunological literature may contain
important clues as to their neuronal functions. Conversely,
some molecules are best known for their neuronal functions,
but are also expressed by immune cells and have less well-char-
acterized functions in the immune response. These include neu-
ropilin 1 (Sarris et al., 2008; Tordjman et al., 2002), agrin (Khan
et al., 2001), semaphorins (Suzuki et al., 2008), GABAA receptors
(Tian et al., 1999), and Dscam. Although Dscam is expressed in
immune tissues, and loss of Dscam impairs the ability of flies
(Watson et al., 2005) and mosquitos (Dong et al., 2006) to fight
bacterial infections, almost nothing is known about how it
performs these immune functions. In particular, although
immune-competent cells possess the capacity to produce thou-
sands of Dscam isoforms (Watson et al., 2005), it is as yet unclear
what, if any, function their incredible isoform diversity serves
in the immune system. In contrast, much more is known about
the circuit and cellular functions of Dscam in the CNS, and about
the role (Chen et al., 2006; Hattori et al., 2007) and even the struc-
tural basis (Meijers et al., 2007; Sawaya et al., 2008) of isoform-
specific Dscam interactions on the surface of neurons. Thus
neuronal studies could provide a framework for imagining how
Dscam might help fight pathogens.Neuron 64, October 15, 2009 ª2009 Elsevier Inc. 105
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perform both immunological and neurological functions in a
single organism. It will be important to determine how these
distinct functions coexist, and the pressures they exert on one
another. Shared molecular machinery could help coordinate
neuronal and immune responses of the disparate systems in
which these proteins function, linking changes in the timing
and magnitude of the two responses. It also increases the risk
of potentially pathological molecular crosstalk. Given that the
precisely tuned functioning of the immune system and the
nervous system are both critical for survival, adaptations may
have arisen to minimize such crosstalk, which if unchecked
could promote autoimmunity, hamper efforts to fight off infec-
tions or cancer, or induce major motor or cognitive impairments.
One speculative idea is that the immune privilege of the brain,
long taken to be evidence that neurons lack key immune
proteins, is instead necessary to preserve the distinct neuronal
functions of these proteins. In this model, rather than being
evidence of a lack of immune proteins, CNS immune privilege
is the opposite: a specialization that is due to the expression
and functional importance of immune proteins in normal brain
development and plasticity.
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